Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Mar 9 |
| SRPT |
| Sarepta Therapeutics, Inc. |
| FTAX |
| 895 |
| $16.95 |
| $15.2K |
| -0.4% |
| Open the original filing on SEC.gov |
| Mar 9 | SRPT | Sarepta Therapeutics, Inc. | FTAX | 504 | $16.95 | $8.5K | -0.2% | Open the original filing on SEC.gov |
| Mar 2 | SRPT | Sarepta Therapeutics, Inc. | FTAX | 767 | $16.20 | $12.4K | -0.3% | Open the original filing on SEC.gov |
| Mar 2 | SRPT | Sarepta Therapeutics, Inc. | FTAX | 3,718 | $16.20 | $60.2K | -1.6% | Open the original filing on SEC.gov |
| Mar 1 | SRPT | Sarepta Therapeutics, Inc. | MEXER◆ | 8,125 | — | — | — | Open the original filing on SEC.gov |
| Mar 1 | SRPT | Sarepta Therapeutics, Inc. | MEXER | 8,125 | — | — | +3.6% | Open the original filing on SEC.gov |
| Feb 25 | SRPT | Sarepta Therapeutics, Inc. | AGRANT◆ | 1,875 | — | — | — | Open the original filing on SEC.gov |
| Nov 17, 2025 | SRPT | Sarepta Therapeutics, Inc. | FTAX | 4,582 | $18.42 | $84.4K | -2.0% | Open the original filing on SEC.gov |
| Sep 3, 2025 | SRPT | Sarepta Therapeutics, Inc. | AGRANT | 50,000 | — | — | +28.0% | Open the original filing on SEC.gov |
| Sep 3, 2025 | SRPT | Sarepta Therapeutics, Inc. | AGRANT | 93,875 | — | — | +110.8% | Open the original filing on SEC.gov |
| Aug 5, 2025 | SRPT | Sarepta Therapeutics, Inc. | AGRANT◆ | 6,250 | — | — | — | Open the original filing on SEC.gov |